Mice lacking ASM failed to mobilise tumour inhibitory macrophages in the region of the tumour cells, and lacked tumour-associated hepatofibroblasts, which secrete the matrix metalloprotease inhibitor TIMP1. Here, SMPD1 is linked to neoplasm.